In an in vitro study on bladder cancer, SFN induced the expression of miR-200c which, in turn, targeted ZEB1, leading to increased E-cadherin expression, suggesting that SFN acts as a TME modulator in this type of cancer (Shan et al., 2013). The gene discussed is SFN; the disease is cancer.